恶性胸膜间皮瘤临床试验影像学评估的标准化共识
由于恶性胸膜间皮瘤罕见、形态复杂且易多平面侵犯,目前缺乏详细的放射学评估指南。2017年3月,美国国家癌症研究所胸部恶性肿瘤指导委员会、国际肺癌研究协会和间皮瘤应用研究基金会共同主办多学科专家会议,制定了针对临床试验入组时影像学评估的共识推荐,涵盖成像参数优化、标准化报告和疗效评估。
要点
- 多学科共识推荐用于恶性胸膜间皮瘤临床试验的影像学评估标准化。
- 共识涵盖成像参数优化、标准化报告和疗效评估。
- 该共识由NCI胸部恶性肿瘤指导委员会、IASLC和MARF共同制定。
核心结论
- 多学科共识为恶性胸膜间皮瘤临床试验中的放射学评估提供了标准化建议。
研究设计与样本
- 2017年3月由美国国家癌症研究所胸部恶性肿瘤指导委员会、国际肺癌研究协会和间皮瘤应用研究基金会共同主办的多学科专家会议。
主要发现
- 会议成果包括建立详细的多学科共识影像和管理指南。
关键数值与推荐
- 推荐涉及跨模态成像参数优化、标准化报告和临床试验中的疗效评估。
临床怎么用
- 在临床试验入组和随访中应用共识推荐的影像学评估、报告和疗效评估标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Detailed guidelines pertaining to radiological assessment of malignant pleural mesothelioma are currently lacking due to the rarity of the disease, complex morphology, propensity to invade multiple planes simultaneously, and lack of specific recommendations within the radiology community about assessment, reporting, and follow-up. In March 2017, a multidisciplinary meeting of mesothelioma experts was co-sponsored by the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and the Mesothelioma Applied Research Foundation. One of the outcomes of this conference was the foundation of detailed, multidisciplinary consensus imaging and management guidelines. Here, we present the recommendations for radiologic assessment of malignant pleural mesothelioma in the setting of clinical trial enrollment. We discuss optimization of imaging parameters across modalities, standardized reporting, and response assessment within clinical trials.
引用
- Gill RR, Tsao AS, Kindler HL, et al. Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting. J Thorac Oncol. 2019. PMID: 31470129. doi:10.1016/j.jtho.2019.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。